I S Fentiman
Overview
Explore the profile of I S Fentiman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
247
Citations
3531
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
4.
Vichapat V, Garmo H, Holmberg L, Fentiman I, Tutt A, Gillett C, et al.
Br J Cancer
. 2012 Jun;
107(2):221-3.
PMID: 22735901
Background: The understanding of metastatic patterns after metachronous contralateral breast cancer (CBC) may help determine the biological nature of CBC. Methods: A cohort of 8478 women with breast cancer treated...
5.
Johnson L, Agbaje O, Doig M, Fentiman I
Breast Cancer Res Treat
. 2012 Jun;
134(2):811-4.
PMID: 22678157
Various studies have suggested that women who smoke have a worse prognosis if they develop breast cancer. Cotinine levels have been measured in sera from 511 patients with stage I...
6.
7.
Pazaiti A, Kontos M, Fentiman I
Int J Clin Pract
. 2011 Dec;
66(1):28-36.
PMID: 22145580
Zearalenone (ZEN) is a non-steroidal mycoestrogen that widely contaminates agricultural products. ZEN and its derivatives share similar molecular mechanisms and activity with estrogens and interact with ERα and ERβ leading...
8.
Kontos M, Allen D, Agbaje O, Hamed H, Fentiman I
Eur J Surg Oncol
. 2011 Aug;
37(12):1051-8.
PMID: 21843919
Background: In breast cancer patients (≥70 years), tumour resection plus tamoxifen (T + T) has a higher loco-regional relapse (LR) rate than mastectomy. This study examines factors influencing local recurrence...
9.
Key T, Appleby P, Reeves G, Roddam A, Helzlsouer K, Alberg A, et al.
Br J Cancer
. 2011 Jul;
105(5):709-22.
PMID: 21772329
Background: Breast cancer risk for postmenopausal women is positively associated with circulating concentrations of oestrogens and androgens, but the determinants of these hormones are not well understood. Methods: Cross-sectional analyses...
10.